Immuron (IMRN) Other Non-Current Assets (2018 - 2023)
Immuron (IMRN) posted quarterly Other Non-Current Assets of $8512.7 for Q4 2023, down 20.42% year-on-year from $10696.6 in Q4 2022, and down 99.34% on a QoQ basis from $1.3 million in Q3 2023.
Immuron (IMRN) Other Non-Current Assets (2018 - 2023) Analysis & Trends
Immuron (IMRN) has reported Other Non-Current Assets for 5 consecutive years, with $8512.7 the latest figure, recorded in Q4 2023.
- Quarterly Other Non-Current Assets fell 20.42% year-over-year to $8512.7 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $8512.7 (down 20.42% YoY) and the FY2023 annual result came in at $18340.3, up 71.46% from the prior year.
- Other Non-Current Assets eased to $8512.7 in Q4 2023 per IMRN's latest filing, from $1.3 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for IMRN reached as high as $17.6 million in Q2 2022 and fell as low as $8512.7 in Q4 2023.
- A 4-year average of $2.9 million and a median of $1.3 million in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2020 — Other Non-Current Assets declined 7.5% — and 2023, when it plunged 89.56%.
- Year by year, Other Non-Current Assets stood at $1.3 million in 2019, then declined by 7.5% to $1.2 million in 2020, then sank by 99.12% to $10696.6 in 2022, then decreased by 20.42% to $8512.7 in 2023.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $8512.7, $1.3 million, and $18340.3 for Q4 2023, Q3 2023, and Q3 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 8,512.66 |
| Sep 28, 2023 | 1.30 Mn |
| Aug 30, 2023 | 18,340.34 |
| Jun 30, 2023 | 1.83 Mn |
| Dec 31, 2022 | 10,696.57 |
| Jun 30, 2022 | 17.56 Mn |
| Jun 30, 2020 | 1.22 Mn |
| Jun 30, 2019 | 1.32 Mn |
| Jun 30, 2018 | 1.53 Mn |